Search results for " emerging markets"
Article
Biopharma Seeks Balance
Biopharma Seeks Balance
Biopharma companies can balance competing demands from patients, investors, and regulators by keeping a focus on science.
By Rita C. Peters
…
Article
Modular Manufacturing Platforms for Biologics
Smaller manufacturing subsystems are best suited for emerging markets where local resources are limited and speed of production is a crucial element (1). A surge capacity is necessary to rapidly scale…
Article
Pharma Investments Reflect Key Industry Trends
The second factor is the shift to production in emerging markets, both because the middle class is increasing and demand for drugs is expected to grow significantly, and in response to individual gove…
Article
Outsourcing Trends in Biopharmaceutical Manufacturing
Trend nine: Emerging markets a bigger part of the equation
Biopharmaceutical facilities are being built by local companies in developing countries to serve their domestic, regional, or lesser-regu…
Article
Single-use Bioreactors Have Reached the Big Time
…rowth of biologics targeting smaller patient populations and the expanding demand for biosimilars in emerging markets has meant that total output needs now fit within the capable production range of …
Article
Report from India
Pharma industry players brace for challenges as India’s new drug-pricing policy kicks in full gear.
(Dmitry Rukhlenko/Getty Images)
On July 1, India's new…
Article
Science Focus Fuels Successful Process Development for Startups
Getting the science right helps biopharma startups overcome development and commercialization challenges.
By Cynthia A. Challener
sdecoret/Stock.Adobe.com
Pr…
Article
The Tide Stays High
Robust venture capital investment gives CDMOs and CROs a positive outlook for 2017.
By Jim Miller
A year ago, the outlook for contract services was a little uncertain. Equity markets’ appeti…
Article
Framing Biopharma Success in 2016
Corporate restructurings, regulatory initiatives, and biosimilars will shape biopharma development in 2016.
By Rita C. Peters
The US biopharmaceutical industry turned a new page in 2015 when…
Article
Finding Opportunities in Brazil
McKinsey & Company, Unlocking Pharma Growth, Navigating the intricacies of emerging markets (McKinsey & Company, 2012), www.mckinsey.com/~/media/mckinsey/dotcom/client_service/pharma and medical produ…